
Artivion, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance
2025-11-10 15:21:17Artivion, Inc., a small-cap company in the Pharmaceuticals & Biotechnology sector, has shown notable resilience with a 54.83% return over the past year, significantly outperforming the S&P 500. Recent evaluations reflect mixed technical indicators, highlighting its strong recovery and robust market position.
Read full news article
Artivion, Inc. Hits New 52-Week High of $47.69, Up 104%
2025-11-07 15:58:12Artivion, Inc. has achieved a new 52-week high of USD 47.69, reflecting a significant increase in its stock price over the past year. With a market capitalization of USD 2,114 million, the company operates in a competitive sector, though it currently reports a negative return on equity.
Read full news article
Artivion, Inc. Hits New 52-Week High of $46.58, Up 96.65%
2025-11-05 16:28:46Artivion, Inc. has achieved a new 52-week high, highlighting its impressive performance with a significant increase over the past year. The company, with a market capitalization of USD 2,114 million, operates in a competitive sector and currently shows a manageable debt level, despite being loss-making.
Read full news article
Artivion, Inc. Hits New 52-Week High of $46.19, Up 96% Yearly
2025-10-31 15:58:59Artivion, Inc. has achieved a new 52-week high, showcasing a significant increase from its previous low and demonstrating strong performance compared to the S&P 500. With a market capitalization of USD 2,114 million, the company operates in a competitive sector, though it remains loss-making and does not offer dividends.
Read full news article





